Pharmaceutical Grade Idp-Na2 Industrial Purity Coa Standards
- Strict QC Protocols: Every batch undergoes rigorous HPLC analysis to ensure pharmaceutical grade specifications.
- Bulk Supply Capability: Scalable manufacturing processes designed for large-volume nucleotide intermediate procurement.
- Documentation: Comprehensive COA provided with full impurity profiling and stability data.
In the realm of advanced biochemical synthesis, the reliability of raw materials dictates the success of downstream applications. Inosine-5'-Diphosphoric Acid Disodium Salt, often referred to as 5'-IDP-Na2, serves as a critical nucleotide intermediate in the production of complex pharmaceuticals and biochemical reagents. For process chemists and procurement managers, verifying the industrial purity of this compound is not merely a regulatory formality but a fundamental requirement for maintaining reaction yields and product safety. As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. adheres to stringent quality control measures to ensure that every shipment meets the exacting standards required for pharmaceutical-grade applications.
The demand for high-purity nucleotides has surged due to their role in synthesizing antiviral agents and immunostimulants. When evaluating suppliers, the Certificate of Analysis (COA) is the primary document for assessing quality. This guide details the technical parameters, testing methodologies, and batch consistency guarantees essential for sourcing this specialized chemical.
Understanding Certificate of Analysis Parameters
A robust COA for 5'-IDP-Na2 must transcend basic identity confirmation. It should provide a comprehensive breakdown of chemical composition, impurity profiles, and physical properties. For industrial buyers, the key parameters include assay purity, residual solvents, heavy metal content, and UV absorption ratios. Pharmaceutical grade specifications typically require an assay purity exceeding 98.0%, with tightly controlled limits on related substances.
Impurity profiling is particularly critical because residual starting materials or side products from the synthesis route can interfere with subsequent enzymatic reactions. A detailed COA will list specific impurities such as Inosine Monophosphate (IMP) or Inosine Triphosphate (ITP), ensuring they remain below threshold limits, usually less than 0.5% individually. Furthermore, parameters like loss on drying and pH value in solution are vital for predicting the stability of the compound during storage and handling. Buyers should request full spectral data, including UV and NMR spectra, to confirm molecular identity alongside chromatographic purity.
HPLC Testing Methods for Industrial Purity
High-Performance Liquid Chromatography (HPLC) is the gold standard for quantifying the industrial purity of Disodium inosine 5'-diphosphate. The method typically employs an anion-exchange column or a reversed-phase C18 column with an ion-pairing agent to achieve adequate separation of the diphosphate species from mono- and tri-phosphate analogs. Detection is usually performed via UV absorbance at 254 nm, where the purine ring exhibits strong absorption.
For bulk procurement, it is essential that the manufacturing partner utilizes validated HPLC methods that are reproducible across different batches. The retention time must be consistent, and the peak resolution between the main product and potential degradants should be greater than 1.5. Advanced facilities also employ LC-MS (Liquid Chromatography-Mass Spectrometry) for trace impurity identification. This level of analytical rigor ensures that the nucleotide intermediate is suitable for sensitive biological applications where even trace contaminants could alter experimental outcomes or compromise drug safety.
Batch Consistency Guarantees for Pharmaceutical Grade
Consistency across production batches is the hallmark of a reliable supply chain. Variations in crystallization conditions or purification steps can lead to differences in particle size distribution and moisture content, which affect flowability and dissolution rates during manufacturing. To mitigate this, producers must implement strict Process Analytical Technology (PAT) controls throughout the synthesis route.
When sourcing high-purity Inosine-5'-Diphosphoric Acid Disodium Salt, buyers should verify that the supplier maintains GMP (Good Manufacturing Practice) compliant facilities. This ensures that environmental controls, equipment cleaning validation, and personnel training are all aligned with pharmaceutical standards. NINGBO INNO PHARMCHEM CO.,LTD. guarantees batch-to-batch consistency through rigorous in-process testing and final release criteria that exceed standard industry requirements.
Storage conditions also play a pivotal role in maintaining purity over time. The compound should be kept in airtight, moisture-resistant containers at controlled room temperature to prevent hydrolysis. A standard retest period is typically 24 months under proper storage conditions, but stability studies should be reviewed to confirm longevity for specific climatic zones.
Technical Specifications Overview
The following table outlines the typical technical specifications expected for pharmaceutical-grade material. These values serve as a benchmark for evaluating supplier COAs.
| Parameter | Specification | Test Method |
|---|---|---|
| CAS Number | 54735-61-4 | N/A |
| Molecular Formula | C10H12N4Na2O11P2 | N/A |
| Assay (HPLC) | ≥ 98.0% | Area Normalization |
| UV Absorbance Ratio (A250/A260) | 0.80 - 0.88 | UV Spectrophotometry |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
| Loss on Drying | ≤ 5.0% | Karl Fischer / Gravimetric |
| pH (1% Solution) | 7.0 - 9.0 | pH Meter |
Procurement and Scalability
Securing a stable supply of Inosine-5'-diphosphate Na2 requires a partner capable of scaling production without compromising quality. Industrial applications often demand kilogram to ton-scale quantities, necessitating a manufacturing process that is both efficient and robust. The bulk price is often correlated with the purity level and the volume of the order, but cost should never supersede the critical quality attributes required for pharmaceutical use.
Engaging with a dedicated global manufacturer ensures access to technical support regarding the integration of this intermediate into your specific synthesis route. Whether used as a biochemical reagent or a PolyI precursor, the integrity of the starting material is paramount. By prioritizing suppliers who provide transparent COAs and validated testing methods, pharmaceutical companies can safeguard their production lines against quality failures.
In conclusion, the selection of Pharmaceutical Grade Idp-Na2 requires a deep understanding of analytical parameters and manufacturing capabilities. With a commitment to excellence, NINGBO INNO PHARMCHEM CO.,LTD. stands ready to support your industrial needs with high-purity intermediates backed by comprehensive documentation and reliable logistics.